被引用紀錄
Chen, S. Y. (2017). 肝細胞癌的初級、次級和三級預防策略之成本效益分析 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201703133
延伸閱讀
- 劉鐘軒、蔡正中、陳海雄（2013）。The Diagnosis and Treatment Strategy of Hepatocellular Carcinoma。內科學誌，24(2)，85-94。https://doi.org/10.6314/JIMT.2013.24(2).02
- Huang, Y. T., & Yen, C. J. (2014). Hepatocellular Carcinoma with Heart Involvement. 台灣癌症醫學雜誌, 1(2), 158-162. https://doi.org/10.6323/JCRP.2014.1.2.10
- 許駿、沈盈君、鄭安理（2008）。Targeted Therapy for Hepatocellular Carcinoma。台灣醫學，12(1)，49-66。https://doi.org/10.6320/FJM.2008.12(1).07
- 許駿（2004）。Study of Systemic Therapy for Hepatocellular Carcinoma〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2004.01876
- Chua, C. W. L., & Choo, S. P. (2011). Targeted Therapy in Hepatocellular Carcinoma. International Journal of Hepatology, 2011(), 123-133. https://doi.org/10.4061/2011/348297